Asp isotopes and isotopia announce supply agreement for gadolinium-160 to accelerate terbium-161 production for advanced cancer therapies

Petach tikva, israel , june 2, 2025 /prnewswire/ -- asp isotopes inc. (nasdaq: aspi) and isotopia molecular imaging ltd. have entered into a strategic agreement to secure the supply of gadolinium-160 (gd-160), a critical precursor isotope for producing terbium-161 (tb-161), an emerging medical isotope with significant potential in targeted radiotherapeutics.
ASPI Ratings Summary
ASPI Quant Ranking